Investigators in the laboratory of Gemma Carvill, Ph.D., assistant professor in the Ken and Ruth Davee Department of Neurology Division of Epilepsy/Clinical Neurophysiology, have discovered novel ...

The Center for Discovery (The Center, TCFD) is pleased to announce that former longtime New York State Assemblywoman Aileen Gunther will become a consultant for the organization. In her new role as a ...

According to the latest study from BCC Research, the demand for Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets is expected to increase from $2.8 billion in 2024 to $5.0 billion ...

Biogen has bolstered its pipeline by licensing ex-US rights to a drug for Dravet syndrome – a rare form of epilepsy – from Stoke Therapeutics in a deal that included an upfront payment of $165 ...

Cannabidiol (CBD) is increasingly recognized for its role as an antiseizure medication, especially for the management of Drug-Resistant Epilepsy (DRE). This ...

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Monday, March 10, 2025. Let’s take ...

Sage Therapeutics (NASDAQ:SAGE) traded lower for the third straight session on Tuesday after Bank of America moved the ...

After hours: March 12 at 7:52:40 PM EDT Loading Chart for STOK ...

For Dravet syndrome and Lennox-Gastaut syndrome, Epidyolex must be used alongside the epilepsy medicine, clobazam. NICE says doctors should check the frequency of seizures every 6 months, and stop ...

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, provided a business ...